{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Early remission status after a 12 week course of pre-operative Somatuline Depot and 3 months after endonasal endoscopic surgery. Remission status will be based on age-adjusted Insulin Glucose Factor 1 (IGF-1) levels and oral glucose tolerance test.","groups":[{"description":"Somatuline Depot SC 90mg deep subcutaneous injection every 4 weeks for 3 doses before surgery. The dose will be 60 mg for patients with mild liver or kidney dysfunction.\n\nlanreotide: Somatuline Depot 90 mg deep subcutaneous injection every 4 weeks X 3 doses","id":"OG000","title":"Somatuline Depot Subcutaneous (SC)"}],"populationDescription":"2 patients treated; data not analyzed because study terminated prematurely.","reportingStatus":"POSTED","timeFrame":"3 months post-op","title":"Early Remission of Acromegaly","type":"PRIMARY"}